NEURELIS TO PRESENT ANALYSES OF IMMEDIATE-USE SEIZURE TREATMENT AT THE AMERICAN ACADEMY OF NEUROLOGY ANNUAL MEETING

Presentations to highlight analyses of both seizure termination and healthcare resource utilization as they relate to use of diazepam nasal spray San Diego, CA – April 16, 2026 – Neurelis, Inc., today announced details of two poster presentations at the American Academy of Neurology (AAN) Annual Meeting to be held April 18-22 in person […] The post NEURELIS TO PRESENT ANALYSES OF IMMEDIATE-USE SEIZURE TREATMENT AT THE AMERICAN ACADEMY OF NEUROLOGY ANNUAL MEETING first appeared on Neurelis, Inc. .